Physician profile
Daniel E Laut
NPI 1225088081
$8,879.71
in general payments reported to CMS, 2019-2025
40 companies · $657 in 2025
The $657 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,203 · 2021: $808 · 2022: $838 · 2023: $866 · 2024: $508 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $5,116.79 | 2019-2021 | |
| Integra Lifesciences Corporation | $864.80 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $310.50 | 2019-2025 | Grafix Pl, Stravix, Renasys Touch |
| Horizon Therapeutics Plc | $274.87 | 2022-2023 | Krystexxa |
| Medtronic, INC. | $221.45 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Paratek Pharmaceuticals, INC. | $210.15 | 2021-2024 | Nuzyra |
| Acumed LLC | $198.57 | 2021-2023 | Osteomed |
| Nevro Corp. | $133.10 | 2024 | Senza |
| Kerecis Limited | $125.05 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Austin Medical Ventures INC | $105.41 | 2022 | |
| Anika Therapeutics, INC. | $104.36 | 2022 | |
| Ethicon US, LLC | $93.46 | 2023 | Surgiflo Hemostatic Matrix, Vistaseal, Evarrest |
| Stryker Corporation | $89.03 | 2022-2025 | Sonopet Iq |
| Mimedx Group, INC. | $85.45 | 2024-2025 | |
| Access Pro Medical, LLC | $82.06 | 2023-2025 | Matriderm, Matriderm |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $71.99 | 2022-2024 | Na, Hammerlock, Motoband |
| Aroa Biosurgery Incorporated | $66.62 | 2022-2024 | |
| Ortho Solutions INC | $58.70 | 2022 | |
| Bioventus LLC | $54.24 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Crossroads Extremity Systems, LLC | $51.40 | 2021 | |
| Next Science LLC | $51.02 | 2023-2024 | Xperience, Surgx, Blastx |
| Lifenet Health | $48.83 | 2025 | Theragenesis Wound Matrix |
| Triad Life Sciences INC. | $46.05 | 2022 | |
| In2bones USA, LLC | $42.78 | 2021 | |
| Zimmer Biomet Holdings, INC. | $41.88 | 2022 | |
| Ets Wound Care LLC | $39.26 | 2023 | |
| Davol INC. | $30.18 | 2025 | Arista |
| Treace Medical Concepts, INC. | $27.51 | 2024 | |
| Amgen INC. | $26.51 | 2024 | Krystexxa |
| Acera Surgical, INC. | $25.20 | 2024 | Restrata Wound Matrix |
| Organogenesis INC. | $24.91 | 2022 | |
| Baxter Healthcare | $23.93 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.87 | 2023 | Jublia |
| Abbvie INC. | $22.67 | 2024 | |
| Sanara Medtech INC. | $21.54 | 2023 | Celleraterx |
| Paragon 28, INC. | $16.39 | 2023 | Phantom Intramedullary Nail |
| Advanced Oxygen Therapy INC. | $13.98 | 2024 | Topical Oxygen Chamber For Extremities |
| Solventum Corporation | $13.23 | 2024 | Activ.A.C. |
| Kci USA, INC. | $12.44 | 2021 | |
| Gramercy Extremity Orthopedics LLC | $9.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Laut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.